<div id="readability-page-1"><div><p>Fujian Cosunter Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2025. For the nine months, the company reported sales was CNY 315.84 million compared to CNY 326.32 million a year ago. Net loss was CNY 111.58 million compared to CNY 70.64 million a year ago.</p><p>Basic loss per share from continuing operations was CNY 0.7006 compared to CNY 0.4435 a year ago. Diluted loss per share from continuing operations was CNY 0.7006 compared to CNY 0.4435 a year ago.</p></div></div>

广生堂

<p>福建广生堂药业有限公司公布了截至 2025 年 9 月 30 日的九个月财报。该公司在这九个月内的销售额为 3.1584 亿元人民币，而去年同期为 3.2632 亿元人民币。净亏损为 1.1158 亿元人民币，而去年同期为 7064 万元人民币。持续经营业务的基本每股亏损为 0.7006 元人民币，而去年同期为 0.4435 元人民币。持续经营业务的摊薄每股亏损为 0.7006 元人民币，而去年同期为 0.4435 元人民币</p>

福建广生堂药业股份有限公司公布了截至2025年9月30日的九个月的财务业绩